Lucid Diagnostics LUCD
NASDAQ LUCD
$0.96 -0.05 (-4.95%)
At close: Aug 20, 2026 · 4:00 PM EDT

Lucid Diagnostics (LUCD) Total Current Liabilities (2021 - 2026)

Lucid Diagnostics' (LUCD) quarterly Total Current Liabilities came in at $29.4 million in Q1 2026, down 19.65% YoY from $36.6 million in Q1 2025, and up 2.81% on a QoQ basis from $28.6 million in Q4 2025.

Lucid Diagnostics (LUCD) Total Current Liabilities (2021 - 2026) Analysis & Trends

Lucid Diagnostics (LUCD) has 6 years of Total Current Liabilities data on file, last reported at $29.4 million in Q1 2026.

  • Quarterly Total Current Liabilities fell 19.65% year-over-year to $29.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.4 million (down 19.65% YoY) and the FY2025 annual result came in at $28.6 million, up 21.5% from the prior year.
  • Total Current Liabilities rose to $29.4 million in Q1 2026, from $28.6 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $36.6 million in Q1 2025 to a low of $7.9 million in Q2 2022.
  • A 5-year average of $22.0 million and a median of $23.5 million in 2024 frame the typical range for Total Current Liabilities.
  • Annual changes were most pronounced in 2023 — Total Current Liabilities soared 248.75% — and 2024, when it sank 52.86%.
  • Tracing LUCD's Total Current Liabilities over 5 years: stood at $8.4 million in 2022, then soared by 248.75% to $29.4 million in 2023, then slipped by 19.94% to $23.5 million in 2024, then rose by 21.5% to $28.6 million in 2025, then climbed by 2.81% to $29.4 million in 2026.
  • The last three Total Current Liabilities figures came in at $29.4 million (Q1 2026), $28.6 million (Q4 2025), and $26.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 17.81 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 6.68 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 11.66 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 6.43 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 1.51 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 2.36 Bn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 8.30 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 8.63 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 1.28 Bn
10 Lucid Diagnostics 175.80 Mn 142.40 Mn 55,000.00 27.52 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 27.52 Mn
Mar 31, 2026 29.39 Mn
Dec 31, 2025 28.58 Mn
Sep 30, 2025 26.21 Mn
Jun 30, 2025 29.43 Mn
Mar 31, 2025 36.57 Mn
Dec 31, 2024 23.52 Mn
Sep 30, 2024 14.25 Mn
Jun 30, 2024 15.98 Mn
Mar 31, 2024 19.98 Mn
Dec 31, 2023 29.38 Mn
Sep 30, 2023 30.22 Mn
Jun 30, 2023 26.68 Mn
Mar 31, 2023 23.39 Mn
Dec 31, 2022 8.43 Mn
Sep 30, 2022 9.70 Mn
Jun 30, 2022 7.88 Mn
Mar 31, 2022 14.11 Mn
Dec 31, 2021 4.26 Mn